🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07580534
Enrolling by invitation Not applicable

Clinical Evaluation of Conventional and 3D-printed Implant-supported Overdentures Retained With New Attachment Systems

NCT07580534 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2024-06-01
Last updated
2026-05-12

Condition(s) studied

Implant Supported OverdentureWear, Occlusal

Investigational drug(s) / intervention(s)

Crossover Assignment

Crossover Assignment: Participants receive Denture A, a conventional mandibular implant overdenture, retained by two Locator ST attachments placed in the interforaminal region. Outcomes include OHIP-19, VAS satisfaction, retention force, attachment wear, periodontal parameters, and denture tooth wear resistance.

Study summary

Randomized Crossover Clinical Trial Comparing Two Denture Designs (A and B) Retained by Two Locator Systems (ST and EMI) in Implant Overdenture Patients

Eligibility

Sex
ALL
Min age
—
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: * Completely edentulous patients * Non-smokers * Patients free from intra-oral diseases that may affect implant-overdenture prognosis * Patients free from systemic conditions that may influence bone resorption or implant success * Able and willing to comply with study visits and follow-up schedule Exclusion Criteria: * Smokers or tobacco users * Presence of active oral lesions, infections, or mucosal pathology * Systemic diseases affecting bone metabolism (e.g., uncontrolled diabetes, osteoporosis requiring bisphosphonates) * History of head and neck radiation * Severe parafunctional habits (e.g., bruxism) * Inability to attend follow-up appointments or provide informed consent

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Faculty of Dental Medicine, Al-Azhar University, (Assiut Branch) Asyut Egypt

More Al-Azhar University trials in Egypt

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07580534 on ClinicalTrials.gov ↗ ← All trials in Egypt